Trials / Unknown
UnknownNCT05807022
Evaluation of the Safety and Effectiveness of Percutaneous and Transbronchial Argon-helium Cryoablation
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- China-Japan Friendship Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The goal clinical trial is to evaluation of the safety and effectiveness of percutaneous and transbronchial argon-helium cryoablation in primary lung cancer and metastatic lung cancer. The main question it aims to answer are:Evaluation of the safety and effectiveness of percutaneous and transbronchial argon-helium cryoablation. Participants will undergo percutaneous or transbronchial argon-helium cryoablation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Percutaneous or transbronchial argon-helium cryoablation | The participants would undergo Percutaneous or transbronchial argon-helium cryoablation. |
Timeline
- Start date
- 2023-03-30
- Primary completion
- 2024-12-01
- Completion
- 2024-12-31
- First posted
- 2023-04-10
- Last updated
- 2023-04-10
Source: ClinicalTrials.gov record NCT05807022. Inclusion in this directory is not an endorsement.